Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches

Mycoses
Shu Yih Chew, Leslie Thian Lung Than

Abstract

Vulvovaginal candidosis (VVC) is a common gynaecological disorder that is delineated by the inflammation of vaginal wall and it is caused by the opportunistic fungal pathogen Candida species. In fact, three out of every four women will experience at least one occasion of VVC during some point in their lives. Although uncomplicated VVC is relatively harmless, the complicated VVC such as recurrent attack often creates restlessness and depression in the patients, thus greatly affects their quality of life. Managements of VVC are usually associated with the use of antimycotic suppositories, topical cream or oral agents. These antimycotic agents are either available over-the-counter or prescribed by the clinicians. In recent decades, the rise of clinical challenges such as the increased prevalence of resistant Candida strains, recurrent VVC infection and adverse effects of multidrug interactions have necessitated the development of novel therapeutic or prophylactic options to combat the complicated VVC in the future. In this review, we discuss the current antimycotic treatments available for Candida vaginitis and the problems that exist in these seemingly effective treatments. Besides, we attempt to contemplate some of the future an...Continue Reading

References

Feb 1, 1992·The British Journal of Dermatology·N S Ryder
Mar 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J D Sobel
Apr 1, 1988·Clinical Microbiology Reviews·R A Fromtling
Jan 1, 1987·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D G StruijkL Arisz
Oct 21, 1968·JAMA : the Journal of the American Medical Association·D Tassel, M A Madoff
Sep 1, 1995·American Journal of Obstetrics and Gynecology·P NyirjesyH R Buckley
Sep 1, 1994·Journal of the American Academy of Dermatology·J D Sobel
May 1, 1994·Journal of the American Academy of Dermatology·A K GuptaN H Shear
Jan 1, 1993·European Journal of Clinical Pharmacology·S Pohjola-SintonenP Neuvonen
Jan 1, 1993·Journal of Clinical Microbiology·J SchmidD R Soll
Mar 24, 1993·JAMA : the Journal of the American Medical Association·P K HonigL R Cantilena
May 1, 1996·Clinical Pharmacokinetics·A J Scheen
Dec 1, 1996·Antimicrobial Agents and Chemotherapy·G D AlbertsonH F Jenkinson
Apr 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J D Sobel, W Chaim
Mar 21, 1998·American Journal of Obstetrics and Gynecology·J D SobelP R Summers
Mar 26, 1998·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·E AlbengresJ P Tillement
Oct 30, 1998·Obstetrics and Gynecology·L O EckertK K Holmes
Nov 13, 1998·Infectious Diseases in Obstetrics and Gynecology·S M Prutting, J D Cerveny
Nov 25, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C T KingS W Chapman
Jul 9, 1999·The Journal of Infectious Diseases·A CassoneR Cauda
Jul 27, 1999·British Journal of Clinical Pharmacology·H T SorensenA E Czeizel
Apr 27, 2000·Sexually Transmitted Diseases·B FoxmanJ D Sobel
Jul 29, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J D Sobel
Aug 5, 2000·Drugs & Aging·N C Nwokolo, F C Boag
Apr 20, 2001·Clinical Pharmacology and Therapeutics·M NiemiK T Kivistö
Jan 30, 2002·Trends in Molecular Medicine·Antonella LupettiSteven Kelly
Feb 28, 2002·Obstetrics and Gynecology·Daron G FerrisMark S Litaker

❮ Previous
Next ❯

Citations

Jan 21, 2017·Journal of Peptide Science : an Official Publication of the European Peptide Society·Siew Mei Samantha NgCheng San Brian Chia
Nov 1, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jaime Pérez-VillanuevaDante B Estrada-Castro
Sep 27, 2018·Future Microbiology·Emanuela EspositoSalvatore Cuzzocrea
Apr 5, 2019·Lasers in Medical Science·Mariana RobattoPatrícia Lordelo
May 2, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Gilbert DondersSarah Lebeer
May 16, 2020·Scientific Reports·Eline F M OerlemansSarah Lebeer
Jun 23, 2018·Lasers in Medical Science·Maria Eugênia Simões Onofre de SantiAlessandro Melo Deana
Oct 31, 2020·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Mariana TomásRita Palmeira-de-Oliveira
Nov 22, 2019·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ghulam AbbasSyed Sikander Azam
Nov 12, 2020·Journal of Fungi·Valentina SustrAlex Farr
May 11, 2021·Journal de mycologie médicale·Rukiye Ada BenderEray Çalışkan
Jun 8, 2021·Revista iberoamericana de micología·Alicia ArechavalaPablo Bonvehí
Jul 12, 2021·Sexual Medicine·Rodger RothenbergerColin MacNeill
Jul 30, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Lara Melo CamposPriscila Faria Pinto
Jun 23, 2020·Current Molecular Pharmacology·Sandeep Kaur, Sukhbir Kaur

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.